Ickleton, United Kingdom

Oliver Taylor Harvey


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Oliver Taylor Harvey

Introduction

Oliver Taylor Harvey, an inventive mind from Ickleton, GB, has made significant strides in the development of medical technology. With a patented invention to his name, he is paving the way for advancements in drug delivery systems, showcasing the potential of innovation in healthcare.

Latest Patents

Harvey's notable patent is a cutting-edge drug injection device, designed to enhance the precision and ease of administering medication. This device features a last dose setting that integrates a main drive pin, a drive wheel, a driven wheel, and an abutment element. The innovative design allows for user-friendly operation through a knob, which enables the drive wheel's rotation. The device ensures that the drug dose is administered accurately by preventing unintended movements, ultimately contributing to patient safety and treatment efficacy.

Career Highlights

Oliver Taylor Harvey is currently associated with Stevanato Group S.p.a., a company known for its dedication to providing advanced solutions in the pharmaceutical sector. With one patent to his credit, Harvey demonstrates a solid foundation in innovation, which is critical in an ever-evolving industry focused on improving patient care.

Collaborations

Throughout his career, Harvey has had the opportunity to collaborate with talented individuals such as Christopher John Hurlstone and Isobel Rachel Sands. These partnerships not only foster creativity but also enhance the collective expertise necessary for developing groundbreaking technologies.

Conclusion

Oliver Taylor Harvey's achievements reflect a commitment to innovation within the medical technology domain. His patented drug injection device signifies a step forward in drug delivery systems and underscores the importance of inventive solutions in improving healthcare outcomes. As Harvey continues to work within Stevanato Group S.p.a., the industry eagerly anticipates his future contributions to medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…